AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IMIPENEM + CILASTATINE
10 registrations across 3 African markets— 4 active
Markets with IMIPENEM + CILASTATINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| PRIMAGAL Poudre pour solution injectable / 500 mg/500 mg | 🇹🇳Tunisia | DEMO SA | expired | Jul 2017 |
| IMIPIMEN/CILASTATINE KABI Poudre pour solution injectable / 500 mg/500 mg | 🇹🇳Tunisia | FRESENIUS KABI FRANCE | expired | Jul 2017 |
| IMIPIMEN/CILASTATINE KABI Poudre pour solution injectable / 250 mg/250 mg | 🇹🇳Tunisia | FRESENIUS KABI FRANCE | expired | Jun 2017 |
| SYNERGIC SET DE TRANSFERT PÉDIATRIQUE Pdre p.prep.injectable / 250 mg/250 mg | 🇹🇳Tunisia | UNIMED | expired | Oct 2009 |
| SYNERGIC IV AVEC SET DE TRANSFERT Pdre p.prep.injectable / 500 mg/500 mg | 🇹🇳Tunisia | UNIMED | expired | Apr 2008 |
| SYNERGIC IV Pdre p.prep.injectable / 500 MG/500 MG | 🇹🇳Tunisia | UNIMED | expired | Jul 2006 |
| IMU-LUX poudre pour solution pour perfusion / 500mg / 500 mg | 🇸🇳Senegal | LUX PHARMA | active | — |
| IMIPENEM/CILASTATIN 1G PPSI PERF IV BTE(1FL X 20ML + SOLV) Poudre pour solution | 🇲🇬Madagascar | EXETER HEALTH LIMITED | active | — |
| IMIPENEM/CILASTATIN 1G PPSI PERF IV BTE(1FL X 20ML + SOLV) Poudre pour solution | 🇲🇬Madagascar | EXETER HEALTH LIMITED | active | — |
| IMU-LUX poudre pour solution pour perfusion / 500mg / 500 mg | 🇸🇳Senegal | LUX PHARMA | active | — |
IMIPENEM + CILASTATINE in Africa — Regulatory Overview
IMIPENEM + CILASTATINE is registered across 3 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Madagascar, Senegal. AfricaRegulatory refreshes this data daily from official government sources.
Of the 10 registrations, 4 (40%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.